BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 29355719)

  • 1. Procancerogenic activity of senescent cells: A case of the peritoneal mesothelium.
    Mikuła-Pietrasik J; Stryczyński Ł; Uruski P; Tykarski A; Książek K
    Ageing Res Rev; 2018 May; 43():1-9. PubMed ID: 29355719
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Colorectal cancer-promoting activity of the senescent peritoneal mesothelium.
    Mikuła-Pietrasik J; Sosińska P; Maksin K; Kucińska MG; Piotrowska H; Murias M; Woźniak A; Szpurek D; Książek K
    Oncotarget; 2015 Oct; 6(30):29178-95. PubMed ID: 26284488
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Senescent peritoneal mesothelium induces a pro-angiogenic phenotype in ovarian cancer cells in vitro and in a mouse xenograft model in vivo.
    Mikuła-Pietrasik J; Sosińska P; Naumowicz E; Maksin K; Piotrowska H; Woźniak A; Szpurek D; Książek K
    Clin Exp Metastasis; 2016 Jan; 33(1):15-27. PubMed ID: 26433963
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Senescent peritoneal mesothelium creates a niche for ovarian cancer metastases.
    Mikuła-Pietrasik J; Uruski P; Sosińska P; Maksin K; Piotrowska-Kempisty H; Kucińska M; Murias M; Szubert S; Woźniak A; Szpurek D; Sajdak S; Piwocka K; Tykarski A; Książek K
    Cell Death Dis; 2016 Dec; 7(12):e2565. PubMed ID: 28032864
    [TBL] [Abstract][Full Text] [Related]  

  • 5. L-Carnosine Prevents the Pro-cancerogenic Activity of Senescent Peritoneal Mesothelium Towards Ovarian Cancer Cells.
    Mikuła-Pietrasik J; Książek K
    Anticancer Res; 2016 Feb; 36(2):665-71. PubMed ID: 26851022
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oxidative stress contributes to hepatocyte growth factor-dependent pro-senescence activity of ovarian cancer cells.
    Mikuła-Pietrasik J; Uruski P; Pakuła M; Maksin K; Szubert S; Woźniak A; Naumowicz E; Szpurek D; Tykarski A; Książek K
    Free Radic Biol Med; 2017 Sep; 110():270-279. PubMed ID: 28652056
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel strategy of ovarian cancer implantation: Pre-invasive growth of fibrin-anchored cells with neovascularization.
    Matsuoka A; Mizumoto Y; Ono M; Kagami K; Obata T; Terakawa J; Maida Y; Nakamura M; Daikoku T; Fujiwara H
    Cancer Sci; 2019 Aug; 110(8):2658-2666. PubMed ID: 31199029
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Intraperitoneal invasiveness of ovarian cancer from the cellular and molecular perspective].
    Sosińska P; Mikuła-Pietrasik J; Kuczmarska A; Książek K
    Ginekol Pol; 2015 Oct; 86(10):782-6. PubMed ID: 26677589
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oxidative stress-dependent increase in ICAM-1 expression promotes adhesion of colorectal and pancreatic cancers to the senescent peritoneal mesothelium.
    Ksiazek K; Mikuła-Pietrasik J; Catar R; Dworacki G; Winckiewicz M; Frydrychowicz M; Dragun D; Staniszewski R; Jörres A; Witowski J
    Int J Cancer; 2010 Jul; 127(2):293-303. PubMed ID: 19904754
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lysophosphatidic acid is constitutively produced by human peritoneal mesothelial cells and enhances adhesion, migration, and invasion of ovarian cancer cells.
    Ren J; Xiao YJ; Singh LS; Zhao X; Zhao Z; Feng L; Rose TM; Prestwich GD; Xu Y
    Cancer Res; 2006 Mar; 66(6):3006-14. PubMed ID: 16540649
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Carcinoma-associated fibroblasts derive from mesothelial cells via mesothelial-to-mesenchymal transition in peritoneal metastasis.
    Sandoval P; Jiménez-Heffernan JA; Rynne-Vidal Á; Pérez-Lozano ML; Gilsanz Á; Ruiz-Carpio V; Reyes R; García-Bordas J; Stamatakis K; Dotor J; Majano PL; Fresno M; Cabañas C; López-Cabrera M
    J Pathol; 2013 Dec; 231(4):517-31. PubMed ID: 24114721
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Senescence of mesothelial cells].
    Mikuła-Pietrasik J; Ksiazek K
    Postepy Biochem; 2014; 60(2):187-93. PubMed ID: 25134354
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Senescent peritoneal mesothelial cells promote ovarian cancer cell adhesion: the role of oxidative stress-induced fibronectin.
    Ksiazek K; Mikula-Pietrasik J; Korybalska K; Dworacki G; Jörres A; Witowski J
    Am J Pathol; 2009 Apr; 174(4):1230-40. PubMed ID: 19246646
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ovarian cancer spheroids use myosin-generated force to clear the mesothelium.
    Iwanicki MP; Davidowitz RA; Ng MR; Besser A; Muranen T; Merritt M; Danuser G; Ince TA; Brugge JS
    Cancer Discov; 2011 Jul; 1(2):144-57. PubMed ID: 22303516
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ovarian cancer-derived ascitic fluids induce a senescence-dependent pro-cancerogenic phenotype in normal peritoneal mesothelial cells.
    Mikuła-Pietrasik J; Uruski P; Matuszkiewicz K; Szubert S; Moszyński R; Szpurek D; Sajdak S; Tykarski A; Książek K
    Cell Oncol (Dordr); 2016 Oct; 39(5):473-481. PubMed ID: 27444787
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel mechanism of neovascularization in peritoneal dissemination via cancer-associated mesothelial cells affected by TGF-β derived from ovarian cancer.
    Fujikake K; Kajiyama H; Yoshihara M; Nishino K; Yoshikawa N; Utsumi F; Suzuki S; Niimi K; Sakata J; Mitsui H; Shibata K; Senga T; Kikkawa F
    Oncol Rep; 2018 Jan; 39(1):193-200. PubMed ID: 29192324
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Senescence induces a proangiogenic switch in human peritoneal mesothelial cells.
    Ksiazek K; Jörres A; Witowski J
    Rejuvenation Res; 2008 Jun; 11(3):681-3. PubMed ID: 18593286
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Where does cellular senescence belong in the pathophysiology of ovarian cancer?
    Książek K
    Semin Cancer Biol; 2022 Jun; 81():14-23. PubMed ID: 33290845
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mesenchymal conversion of mesothelial cells as a mechanism responsible for high solute transport rate in peritoneal dialysis: role of vascular endothelial growth factor.
    Aroeira LS; Aguilera A; Selgas R; Ramírez-Huesca M; Pérez-Lozano ML; Cirugeda A; Bajo MA; del Peso G; Sánchez-Tomero JA; Jiménez-Heffernan JA; López-Cabrera M
    Am J Kidney Dis; 2005 Nov; 46(5):938-48. PubMed ID: 16253736
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pro-cancerogenic effects of spontaneous and drug-induced senescence of ovarian cancer cells in vitro and in vivo: a comparative analysis.
    Rutecki S; Szulc P; Pakuła M; Uruski P; Radziemski A; Naumowicz E; Moszyński R; Tykarski A; Mikuła-Pietrasik J; Książek K
    J Ovarian Res; 2022 Jul; 15(1):87. PubMed ID: 35883110
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.